Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Trademark Information

Application ID
Status
Sub Status
Date of Application
18 July 2019
Classes
5
Proprietor
Level 17, 31 Queen Street Melbourne Vic 3000 Au
Attorney
Azb & Partners[2594]
Plot No. A 8 Sector 4 Noida 201301
Type
Device
State
State Not Specified
Country
Filing Mode
International Bureau
IP Office
IR DIVISION
Used Since
Valid / Upto
Description
[Class : 5] Cellular Function Activating Agents For Medical Purposes; Therapeutic Pharmaceutical For The Treatment Of Wounds, Skin Conditions, Orthopaedic Conditions Including Sarcopenia, Osteoarthritis And Tendinopathy, Degenerative Eye Disease Including Age Related Macular Degeneration, Age Related Conditions, Neurodegenerative Disease, Depression, Bleeding, Trauma, Stroke, Heart Disease.

Image (DEVICE)

Polaris Device mark 4270514 Trademark
Sign In to Follow Application
All Documents & Correspondence

Uploaded Documents

1 Birth 19 Aug 2019
2 Reply to Exam Report (MIS-R) 16 Oct 2019
3 TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) 17 Oct 2019
4 Authorization Letter 06 Mar 2020
5 Reply to Exam Report (MIS-R) 11 Mar 2020
6 Journal Copy 17 Sep 2020
7 Journal Copy 17 Sep 2020
8 Journal Copy 17 Sep 2020

Correspondence and Notices

1 Hearing Notice (Show Cause) 9588564 4717744 16 Jan 2020
2 Tribunal Accepted Notice for : 4270514 9904878 4863332 11 Mar 2020

Frequently Asked Questions

Date on which the trademark application was filed with TMO?
Pop-pop was applied on 18 July 2019.
Who is the trademark proprietor?
Trademark application was filed by Exopharm Limited.
Trademark application is filed under which trademark class?
Trademark application has been filed under classes 5.
Trademark application is at what stage of trademark process?
As per IP India, trademark application status is Protection Granted.
What is the Listed Application ID of the Trademark?
Listed application Id of Pop-pop is 4270514.
Who filed the trademark on behalf of the proprietor?
Trademark attorney of the Pop-pop is Azb & Partners.